Greetings!

Welcome to the Monthly QPS Clinical Newsletter

Discover the scope of QPS global, full-service clinical research operations services, understand our comprehensive oncology clinical trials expertise, and stay informed with the latest scientific breakthroughs and insights in the QPS blog.

QPS Clinical Research Services

With offices in USA, Europe, Asia, Australia, and India, and a site network of over 700 locations, QPS global, full-service clinical research services encompass comprehensive support for the development and approval of new therapies across all phases of clinical development. These services typically include study design, site selection, regulatory affairs, patient recruitment, clinical trial management, data collection and analysis, pharmacovigilance, and biostatistics, supported by robust laboratory services, such as preclinical studies (pharmacology, toxicology and DMPK) and bioanalysis.

Explore the White Paper, Five Criteria to Use When Selecting a CRO

Why Choose QPS for Oncology Clinical Trials?

QPS has extensive expertise in Phase I oncology clinical studies, having successfully conducted over 50 oncology studies across Asia, Europe, and the United States. Our experience includes a diverse spectrum of cancers, such as breast, head & neck, lung, and prostate cancer among others.

QPS provides comprehensive services from initial planning through to execution, including Regulatory and Medical Affairs.

Contact QPS to Discuss Your Oncology Clinical Trial

Discover the Future of Science on the QPS Blog

Injecting Hope: Early Steps Toward Prenatal Treatment for Genetic Disorders

The potential to treat severe genetic disorders before birth has taken a promising step forward. Researchers at the University of California, San Francisco (UCSF) are exploring the feasibility of injecting therapies directly into the...

In Utero Gene Therapies

Gene Therapy at QPS

Sight Concerns: Investigating the Link Between GLP-1 RA Medications and Eye Health

Glucagon-like peptide (GLP-1) receptor agonists (GLP-1 RAs) are transformative medications for millions of people managing diabetes and obesity. Amid research demonstrating the many benefits gained from these drugs...

Risks and Benefits of GLP-1s

Obesity Research at QPS

Subscribe to the QPS Blog

Visit our website www.qps.com

or contact us at infopr@qps.com

for an appointment.

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)